Fig. 8From: Elucidating shared biomarkers and pathways in kidney stones and diabetes: insights into novel therapeutic targets and the role of resveratrolGSEA between kidney stones subtypes based on IL11 expression levels. A GO:BP analysis via GSEA. B GO:CC analysis via GSEA. C GO:MF analysis via GSEA. D KEGG pathway analysis via GSEA. E Hallmark pathway analysis via GSEA. F Reactome pathway analysis via GSEA. G Enriched immune cell types via GSEABack to article page